VSEE · Vsee Health, Inc. · Executive Compensation
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that principal conditions including the Company’s liquidity condition and historical operating losses raise substantial doubt about the Company’s ability to continue as a going concern for a period of time of at least one year after the date that the accompanying consolidated financial statements are issued. ... There is no assurance that the Company’s plans to alleviate such concerns will be successful or successful within one year after the date the condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
One customer — 46% of revenue (the three months ended June 30, 2026)
“The Company has one customer whose revenue accounted for approximately 46% and 43% of the Company's total revenue for the three months ended June 30, 2026, and six months ended June 30, 2026, respectively.”
One customer — 43% of revenue (the six months ended June 30, 2026)
“The Company has one customer whose revenue accounted for approximately 46% and 43% of the Company's total revenue for the three months ended June 30, 2026, and six months ended June 30, 2026, respectively.”
2 customers — 23% of receivables (June 30, 2026)
“In aggregate, the Company had two customers whose accounts receivable represented 23% of the Company's total accounts receivable as of June 30, 2026.”
3 customers — 43% of receivables (December 31, 2025)
“In the aggregate, the Company had three customers whose accounts receivable represented 43% of the Company's total accounts receivable as of December 31, 2025.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Scott Metzger | member of the Board of Directors | Resigned | 2026-08-31 |
| Milton Chen | chairman of the board of directors | Resigned | 2026-06-05 |
| Milton Chen | co-Chief Executive Officer | Resigned | 2026-06-05 |
| David L. Wickersham | Class III director | Appointed | 2024-07-23 |
| Cydonii V. Fairfax | Class III director | Appointed | 2024-07-23 |
| Jerry Leonard | CFO | Appointed | 2024-06-28 |
| Imoigele "Imo" P. Aisiku | co-CEO | Appointed | 2024-06-28 |
| Milton Chen | co-CEO | Appointed | 2024-06-28 |
| Imoigele Aisiku | Co-Chief Executive Officer of the Company | Appointed | 2024-06-28 |
| Jerry Leonard | Chief Financial Officer and Secretary of the Company | Appointed | 2024-06-28 |
| Colin O'Sullivan | directors of the Company | Appointed | 2024-06-28 |
| Milton Chen | Co-Chief Executive Officer of the Company | Appointed | 2024-06-28 |
| Imoigele Aisiku | directors of the Company | Appointed | 2024-06-28 |
| Milton Chen | directors of the Company | Appointed | 2024-06-28 |
| Kevin Lowdermilk | director | Appointed | 2022-10-20 |
| Brent Willis | board of directors | Resigned | 2022-10-20 |
Leadership
- Imoigele "Imo" P. Aisiku CEO
- Imoigele Aisiku CEO, Board Member
- Milton Chen CEO, Board Member
- Jerry Leonard CFO
- Colin O'Sullivan Board Member
- Colin O’Sullivan Board Member
- Cydonii V. Fairfax Board Member
- David L. Wickersham Board Member
- Kevin Lowdermilk Board Member